The dramatic changes in the pharmaceutical and healthcare market, such as increasing cost pressure, increased globalisation of supply chains, varying national requirements for marketing authorisation documentation and the opening up of new markets, are forcing companies in the pharmaceutical industry to adopt new strategies and make efficient adjustments. Companies, especially small and medium-sized enterprises, have to concentrate on their strengths and core competencies and manage costs.
Market success heavily depends on product quality, which must be continuously adjusted, improved and maintained to keep up with the latest scientific developments. Companies affected by these developments are often no longer able to maintain the full extent of infrastructure and resources to meet these requirements. Even the OTC divisions in large, multinational corporations are buckling under the weight of assigning priority to research and development, because the relevant resources are engaged in "Big Point Innovations", leaving no resources available for other developments, such as in the herbal medicinal product area. The same applies to the development, adaptation and implementation of analytical methods and the capacities available in the in-house laboratories.
You can now delegate relevant tasks in your portfolio to an experienced service provider with decades of experience and expertise in a variety of areas, such as development projects, marketing authorisation procedures, amendment and maintenance of existing marketing authorisations, and even stability and release testing. As a partner, we help you to solve product-specific problems and manage the execution of defined projects. We look forward to working with you!